Brief: Caribou Biosciences Provides Regulatory Update On Cb-010 Pivotal Plan

Caribou Biosciences

12/12/2023 21:10

Dec 12 (Reuters) - Caribou Biosciences Inc  CRBU.O :
    * CARIBOU BIOSCIENCES PROVIDES REGULATORY UPDATE ON CB-010
PIVOTAL
PLAN WITH PHASE 3 TRIAL INITIATION EXPECTED BY YE 2024
    * CARIBOU BIOSCIENCES INC - CARIBOU PLANS TO INITIATE PHASE
3
PIVOTAL TRIAL BY YE 2024
    * CARIBOU BIOSCIENCES INC - CARIBOU PLANS TO INITIATE PHASE
3
PIVOTAL TRIAL BY YE 2024
    * CARIBOU BIOSCIENCES INC - ANTLER PHASE 1 TRIAL CONTINUES
DOSE
EXPANSION ENROLLMENT; INITIAL DOSE EXPANSION DATA AND RP2D
EXPECTED Q2 2024

Source text for Eikon:  ID:nGNXNcngW 
Further company coverage:  CRBU.O 

 ((Reuters.Briefs@thomsonreuters.com;))